65,437 trials
Meningococcal Meningitis
Primary: Percentages of Subjects With Human Complement Serum Bactericidal Activity (hSBA) Titers≥ 1:8, After One Dose of Either MenACWY-CRM Conjugate or Licensed Comparator…
Type 2 Diabetes Mellitus
Primary: Percent Change in Hemoglobin A1c — -0.41; -0.14 percentage change of hemoglobin A1c — p=0.0369
Type 2 Diabetes Mellitus
Primary: Percent Inhibition of Dipeptidyl Peptidase IV (DPP-4) Activity at Trough — 91.73; 73.50; 28.88; 90.63 Percent inhibition — p=<.001
Wound Healing
Primary: Proportion of Participants With Skin Irritation Scores at 24 Hours — 75.0; 91.7; 94.4; 94.4 Percentage of participants
Renal Transplantation
Primary: Percentage of Participants With Main Reason for the Use of Sirolimus (Rapamune) Therapy — 40.38; 25.00; 5.77; 5.77 percentage of participants
Recurrent Melanoma · Stage IV Cutaneous Melanoma AJCC v6 and v7
Primary: Tumor Response Rate — 7.7 percentage of patients
Adenocarcinoma of the Gastroesophageal Junction · Diffuse Adenocarcinoma of the Stomach · Intestinal Adenocarcinoma of the Stomach
Primary: Overall Response Rate — 1; 0; 4; 1 participants
Pneumonia · Lower Respiratory Tract Infection
Primary: Pneumonia — 119; 94 participants
Brenner Tumor · Fallopian Tube Cancer · Ovarian Clear Cell Cystadenocarcinoma
Primary: Objective Response by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria (Version 1.1) — 1; 8; 1; 12 participants
Asthma
Primary: Gene Expression in Airway Secretions and Tissues — -0.66; 0.54; -0.30 Relative gene expression level
Dyslipidemias · Diabetes Mellitus, Type 2
Primary: The Change From Baseline in Mean Serum High Density Lipoprotein Cholesterol Concentration After 91 Days (13 Weeks) of Treatment — 0.00; 0.04; -0.04; 0.00 mmol/l — p=0.766
Refractive Ametropia
Primary: Subject Reported Overall Quality of Lens Vision Using the Contact Lens User Evaluation (CLUE) Questionnaire — 54.06; 53.06 units on a scale
Knee Osteoarthritis
Primary: Change of Pain Over 26 Weeks (Change From Baseline) — -4.13; -4.00; -4.90 units on a scale
Anemia
Primary: RBC Transfusions Per Subject Receiving a Transfusion — 2.3; 3.9 units — p=<0.01
Activities of Daily Living · Caregivers · Ambulatory Surgical Procedures
Primary: Functional Autonomy Measurement System (SMAF) — 4.0; 2.0; 10.9; NA units on a scale